Oncorus, Inc.

General Information


We are a clinical-stage biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients. Using our two distinct proprietary platforms, we are developing a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. 



Industry: Pharmaceuticals
Employees: 40
Founded: 2015
Contact Information
Address 50 Hampshire Street, Suite 401 Cambridge, Massachusetts 02139
Phone Number (857) 320-6400
Web Address
View Prospectus: Oncorus, Inc.
Financial Information
Market Cap $327.75mil
Revenues $0 mil (last 12 months)
Net Income $-33.6 mil (last 12 months)
IPO Profile
Symbol ONCR
Exchange NASDAQ
Shares (millions): 5.8
Price range $15.00 - $15.00
Est. $ Volume $87.0 mil
Manager / Joint Managers Jefferies/ Evercore/ Piper Sandler
Expected To Trade: 10/2/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change